Trial Recruitment Closes On Novo’s Next Big Semaglutide Bet: Alzheimer’s Disease

Twin EVOKE Studies Aim To Prove Neurological Benefits

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.